From October 1, 2023 to November 14, 2023, the company has repurchased 765,600 shares, representing 0.16% for CNY 48.59 million. With this, the company has completed the repurchase of 787,600 shares, representing 0.17% for CNY 49.99 million under the buyback announced on September 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.19 CNY | -2.19% |
|
-3.24% | -56.54% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.54% | 173.91Cr | |
-18.02% | 842.98Cr | |
+69.46% | 435.3Cr | |
+7.88% | 277.58Cr | |
-1.93% | 263.74Cr | |
-14.28% | 177.14Cr | |
-16.69% | 147.71Cr | |
+17.87% | 121.56Cr | |
-49.60% | 102.29Cr | |
+10.83% | 92Cr |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.